Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer-Associated Diabetes.

Wei-Chih LiaoBo-Shih HuangYa-Han YuHsin-Hua YangPeng-Ruei ChenCheng-Chieh HuangHsin-Yi HuangMing-Shiang WuLu-Ping Chow

Published in: Diabetes care (2019)

Galectin-3 and S100A9 are overexpressed in PCDM tumors and mediate insulin resistance. Galectin-3 and S100A9 distinguish PCDM from type 2 diabetes in subjects with new-onset diabetes.

Keyphrases

type diabetes
glycemic control
insulin resistance
cardiovascular disease
adipose tissue
high fat diet
polycystic ovary syndrome
high fat diet induced
weight loss